Clinical Trial

Subcision With Injection of Poly Deoxyribonucleotide Versus Subcision With Injection of Non-cross Linked Hyaluronic Acid in Rolling Acne Scars Treatment.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 18, 2026 (before its estimated June 20, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate and compare the efficacy and safety of two different injectable agents combined with subcision for treating rolling acne scars. In this split-face clinical trial, each participant will receive subcision on both sides of the face. One side will then be treated with an injection of Polydeoxyribonucleotide (PDRN), while the other side will receive an injection of non-cross linked Hyaluronic acid (HA). The clinical outcomes and improvement in scar appearance will be assessed and compared between both treatments
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-19
Trial Details
NCT Number NCT07547956
Lead Sponsor Cairo University
Conditions Atrophic Acne Scars
Enrollment 20 participants
Start Date 2025-10-20
Primary Completion 2026-06-20 (estimated)
Study Completion 2026-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-18